ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1611

Gene Expression Profiling Reflects Increased Expression of Coronary Artery Disease Associated Genes in a Case-Control Matched Study of Patient with Rheumatoid Arthritis

Erica Peart1, Kim Huffman2, William E. Kraus3, Phil Beineke4, Jim Wingrove4 and Steve Rosenberg4, 1Rheumatology, Duke University Medical Center, Durham, NC, 2Durham Veterans Affairs Medical Center, Durham, NC, 3Duke Pepper Center, Durham, NC, 4CardioDx, Redwood City, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease and rheumatoid arthritis (RA), Gene Expression

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Peripheral blood gene expression profiling has been used to identify gene signatures which reflect a variety of pathologic conditions.  The CorusCAD¨ test is a peripheral blood gene expression test incorporating age, sex, and gene expression into an algorithm which assesses obstructive CAD (coronary artery disease) likelihood in non-diabetic patients without inflammatory diseases.  Our objective was to evaluate the validity of the CorusCAD¨ expression profile with CAD in persons with rheumatoid arthritis (RA), a chronic inflammatory condition. 

Methods:

Twenty RA-non RA, case-control matched pairs of individuals with a range of known CAD were identified in a large cardiac catheterization cohort, CATHGEN.   Rheumatoid arthritis patients were identified using ICD9 codes, and diagnosis was confirmed by chart review.  Controls, without RA, were matched by sex, age, race, number of diseased coronary vessels, and BMI.  Persons with type 2 diabetes were excluded.  Gene expression levels of 23 CAD-associated genes composing the CorusCAD¨ score were used to determine the age, sex, gene expression scores (ASGES).   ASGES were compared in RA and controls using a matched pair analytic approach (paired t-test).

Results:

In persons with RA, the range of CorusCAD¨ ASGES scores was similar for those with and without RA.  Independent of CAD, persons with RA had higher Corus ASGES scores than matched controls (P<0.04).  Specifically, RA contributed to a 10% increase in CorusCAD¨ ASGES when controlling for CAD using the matched design.  RA was associated with higher expression levels for  6 of the 23 genes (P<0.05 for all, not adjusted for multiple comparisons): S100 calcium binding protein A12; interleukin-18 receptor accessory protein; caspase 5; S100 calcium binding protein A8; aquaporin 9; and cluster of differentiation (CD)79b.  All except aquaporin 9 are associated with higher expression in CAD.  

Conclusion:

Across a range of known coronary disease severity, RA is associated with increased expression of CAD-associated genes; among these are two genes associated with neutrophil activation, S100A8 and S100A12.  Both are associated with RA disease activity in published studies.  Further work on the mechanism and consequences of gene activation for these genes is indicated.


Disclosure: E. Peart, None; K. Huffman, None; W. E. Kraus, None; P. Beineke, CardioDx, 1,CardioDx, 3; J. Wingrove, CardioDx, 1,CardioDx, 3; S. Rosenberg, CardioDx, 1,CardioDx, 5.

To cite this abstract in AMA style:

Peart E, Huffman K, Kraus WE, Beineke P, Wingrove J, Rosenberg S. Gene Expression Profiling Reflects Increased Expression of Coronary Artery Disease Associated Genes in a Case-Control Matched Study of Patient with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/gene-expression-profiling-reflects-increased-expression-of-coronary-artery-disease-associated-genes-in-a-case-control-matched-study-of-patient-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gene-expression-profiling-reflects-increased-expression-of-coronary-artery-disease-associated-genes-in-a-case-control-matched-study-of-patient-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology